From: A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia
Statement | R1 N | R1 % Agree†(IQD) | R2 % Agree†(IQD) |
---|---|---|---|
Central nervous system (CNS) abnormalities | |||
Assessment of CNS abnormalities in FASD screening may include: | |||
1. … developmental milestones | 80 | 96 (1) | - |
2. … motor and sensory function | 77 | 88 (1) | - |
3. … cognition (IQ) | 79 | 92 (1) | - |
4. … memory | 78 | 89 (1) | - |
5. … academic achievement | 79 | 91 (1) | - |
6. … executive functioning and abstract reasoning | 79 | 89 (1) | - |
7. … adaptive behaviour | 75 | 92 (1) | - |
8. … attention and hyperactivity | 80 | 95 (1) | - |
9. … communication (receptive and expressive language) | 78 | 94 (1) | - |
10. … social skills and social communication | 80 | 93 (1) | - |
11. … hard and soft neurologic signs (including sensory-motor signs) | 74 | 87 (1) | - |
12. … seizures that are not due to a postnatal insult or other postnatal process | 74 | 78 (1) | - |
13. … head circumference | 78 | 96 (1) | - |
14. … brain imaging | 67 | 57 (1) | - |
The choice of tests for neuro-behavioural assessments should be guided by: | |||
15. … the availability of valid and reliable instruments | 76 | 90 (1) | - |
16. … clinician preference and experience | 74 | 60 (2) ‡ | - |
17. … test appropriateness for patient age and cultural background | 78 | 97 (1) | - |
18. At the screening stage it is not necessary to formally assess and measure suspected CNS anomalies | 68 | - | 72 (1) |
At the screening stage the following are acceptable indicators of possible CNS abnormalities (neurological, functional or structural): | |||
19. … clinical identification | 66 | - | 97 (0) |
20. … parent or other credible third party report | 66 | - | 91 (0) |
21. … results of previous relevant formal assessments (e.g. psychological report) | 65 | - | 100 (1) |
Birth defects | |||
22. FASD screening should assess and record the presence of birth defects as part of the clinical examination | 81 | 99 (1) | - |